J&J's announcement came just hours after GSK confirmed it had agreed a $1 billion deal to buy cancer biotech IDRx and its KIT inhibitor for gastrointestinal stromal tumours (GIST). If completed ...

Concord Biotech Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 15,933.05 Crore) operating in Pharmaceuticals sector. Concord Biotech Ltd. key Products/Revenue ...